Articles Tagged With: diabetes
-
Donislecel-jujn Allogenic Pancreatic Islet Cellular Suspension (Lantidra)
Lantidra can be prescribed to adults with type 1 diabetes who cannot approach target HbA1c levels because of current repeated episodes of severe hyperglycemia despite intensive diabetes management and education.
-
Hispanic Patients with Diabetes Need Better Care Transition Models
About one in 10 Americans are diagnosed with diabetes, and the Hispanic/Latino population is disproportionately affected. Their risk is higher — and their outcomes are worse — than the white, non-Hispanic population. Researchers designed a transition of care model and pilot to see if they could improve outcomes.
-
A Review of Insulin Transition
Diabetes mellitus is a collection of chronic metabolic diseases that occur either as the result of insulin deficiency or insulin resistance. One of the primary goals in diabetes treatment includes lowering blood glucose levels sufficiently to prevent microvascular and macrovascular complications. The type of insulin prescribed depends on multiple factors, and insulins frequently are interchanged. Before choosing or transitioning to an appropriate insulin, consider all social determinants and individualize the treatment regimen as “one size does not fit all.”
-
Teplizumab-mzwv Injection (Tzield)
Teplizumab can be prescribed to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients age 8 years and older with stage 2 type 1 diabetes.
-
Telehealth Monitoring Helps At-Risk Patients with Diabetes
Standard care for patients with persistently poor control of type 2 diabetes does not always work well. Investigators studied different telehealth interventions designed for this group. They found comprehensive telehealth improved multiple outcomes in patients with persistently poorly controlled type 2 diabetes.
-
Are SGLT2 Inhibitors Effective for HFpEF Patients Without Diabetes?
After comparing empagliflozin to placebo for patients with heart failure and preserved left ventricular ejection fraction, researchers found no differences in the significant reduction of the primary outcome of cardiovascular death or heart failure hospitalization over 36 months based on whether patients were diabetic.
-
Are SGLT2 Inhibitors Effective for HFpEF Patients Without Diabetes?
After comparing empagliflozin vs. placebo for patients with heart failure and preserved left ventricular ejection fraction, researchers found no differences in the significant reduction of the primary outcome of cardiovascular death or heart failure hospitalization over 36 months based on whether patients were diabetic.
-
Answering Patient Questions About COVID-19
Wright State University Boonshoft School of Medicine formed an educational task force to educate clinicians and answer community members’ questions about all things COVID-19. Easily referenced resources on COVID-19 are essential for healthcare professionals in speaking with patients. Easy-to-navigate, dependable, up-to-date sources of information help serve patients requiring specific and timely answers to questions. Having a “go-to” list of resources can reduce confusion about COVID-19, making vaccination updates and other conversations more productive.
-
Diabetic Emergencies: Part II
This issue concludes our two-part discussion of diabetic emergencies. Part I covered pathophysiology and clinical presentation, and part II will cover diagnostic evaluation and management.
-
Virtual Diabetes Boot Camp Helps Patients Improve
A virtual diabetes boot camp program can help patients improve their health, even when it is difficult to attend in-person appointments.